Bortezomib-induced peripheral neurotoxicity: A neurophysiological and pathological study in the rat
- 1 March 2007
- journal article
- Published by Elsevier in Experimental Neurology
- Vol. 204 (1) , 317-325
- https://doi.org/10.1016/j.expneurol.2006.11.010
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- Proteasome Inhibitors Trigger NOXA-Mediated Apoptosis in Melanoma and Myeloma CellsCancer Research, 2005
- Morphological and morphometric analysis of paclitaxel and docetaxel-induced peripheral neuropathy in ratsEuropean Journal Of Cancer, 2005
- Bortezomib or High-Dose Dexamethasone for Relapsed Multiple MyelomaNew England Journal of Medicine, 2005
- Phase 1 trial of the proteasome inhibitor bortezomib and pegylated liposomal doxorubicin in patients with advanced hematologic malignanciesBlood, 2005
- A phase 2 study of two doses of bortezomib in relapsed or refractory myelomaBritish Journal of Haematology, 2004
- Phase II Trial of Bortezomib for Patients With Advanced Renal Cell CarcinomaJournal of Clinical Oncology, 2004
- Synergistic Induction of Oxidative Injury and Apoptosis in Human Multiple Myeloma Cells by the Proteasome Inhibitor Bortezomib and Histone Deacetylase InhibitorsClinical Cancer Research, 2004
- rhGGF2 protects against cisplatin-induced neuropathy in the ratJournal of Neuroscience Research, 2000
- Effect of Recombinant Human Nerve Growth Factor on Cisplatin Neurotoxicity in RatsExperimental Neurology, 1999
- The role of the ubiquitin-proteasome pathway in apoptosisCell Death & Differentiation, 1999